These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ribosomal immunostimulation: assessment of studies evaluating its clinical relevance in the prevention of upper and lower respiratory tract infections in children and adults. Bellanti J, Olivieri D, Serrano E. BioDrugs; 2003; 17(5):355-67. PubMed ID: 14498765 [Abstract] [Full Text] [Related]
4. Rationale for the clinical use of a ribosome-component immune modulator. Pregliasco F, Terracciano L, Marcassa S, Zava D, Anselmi G. Allergy Asthma Proc; 2009; 30 Suppl 1():S5-12. PubMed ID: 19679000 [Abstract] [Full Text] [Related]
5. Prevention of recurrent respiratory tract infections in children using a ribosomal immunotherapeutic agent: a clinical review. Bousquet J, Fiocchi A. Paediatr Drugs; 2006; 8(4):235-43. PubMed ID: 16898854 [Abstract] [Full Text] [Related]
10. Diversity of mucosal immune responses in upper respiratory organs and its application for mucosal vaccine. Kurono Y, Miyashita K, Makise T, Nagano H. Adv Otorhinolaryngol; 2011; 72():146-8. PubMed ID: 21865715 [Abstract] [Full Text] [Related]
11. Ribosome-component immune modulation of respiratory tract infections in adults. Olivieri D, Chiesa S, Tzani P, Marino P, Robberto E, Marcassa S. Allergy Asthma Proc; 2009; 30 Suppl 1():S13-9. PubMed ID: 19679001 [Abstract] [Full Text] [Related]
12. Vaccines nonspecific - immunostimulation in patients with recurrent respiratory infections. Paśnik J. Otolaryngol Pol; 2016 Dec 20; 70(6):31-39. PubMed ID: 28485282 [Abstract] [Full Text] [Related]
13. Non-specific immune stimulation in respiratory tract infections. Separating the wheat from the chaff. Feleszko W, Ruszczyński M, Zalewski BM. Paediatr Respir Rev; 2014 Jun 20; 15(2):200-6. PubMed ID: 24275566 [Abstract] [Full Text] [Related]